Label: ACETAMINOPHEN 325MG- acetaminophen tablet

  • NDC Code(s): 10135-828-01
  • Packager: Marlex Pharmaceuticals Inc
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated February 1, 2026

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • Active Ingredient(in each tablet)

    Acetaminophen USP 325 mg

  • Purpose

    Pain Reliever/Fever Reducer

  • Uses

    To reduce fever and for the temporary relief of minor aches and pains due to:

    • Headache
    • Backache
    • The common cold
    • Premenstrual and menstrual cramps
    • Temporarily reduces fever
    • Muscular ache
    • Minor pain of arthritis
    • Toothache
  • Warnings

    Liver warning:this product contains acetaminophen.

    Severe liver damage may occur if

    • adult takes more than 12 tablets in 24 hours, which is the maximum daily amount
    • child takes more than 5 doeses in 24 hours
    • taken with other drugs containing acetaminophen
    • adult has 3 or more alcoholic drinks every day while using this product

    Do not use

    • with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.
    • if you are allergic to acetaminophen or any of the inactive ingredients in this product.

    Ask a Doctor

    before use if you have liver disease.

    Ask a doctor or pharmacist before use

    if you are taking the blood thinning drug warfarin.

    Stop use and ask a doctor if

    • Pain gets worse or lasts more than 10 days in adults and children.
    • Pain gets worse or lasts more than 5 days in children under 12 years.
    • Fever gets worse or lasts more than 3 days.
    • New symptoms occur.
    • Redness or swelling is present.

    These could be signs of a serious condition.

    If pregnant or breast-feeding,

    ask a health professional before use.

    Keep out of reach of children.

    Overdose warning:

    Taking more than the recommended dose (overdose) may cause liver damage. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222). Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

  • Directions

    Do not take more than directed

    Adults and Children 12 years and over:

    • Take 2 tablets every 4 to 6 hours while symptoms last.
    • Do not take more than 12 tablets in 24 hours

    Children 6-11 years:

    • Take 1 tablet every 4 to 6 hours while symptoms last.
    • Do not take more than 5 tablets in 24 hours.

    Children under 6years:

    Do not use this adult regular strength product in children under 6 years of age; this will provide more than the recommended dose (overdose) of acetaminophen and may cause liver damage.

  • Other Information

    • Store between 20-25 ˚C (68-77 ˚F).
  • Inactive Ingredients

    Pregelatinized Starch, Povidone K 30, Sodium starch Glycolate, Stearic Acid.

    Manufactured for/ Distributed by:
    Marlex Pharmaceuticals, Inc.
    New Castle, DE 19720

    Rev. 01/26 AA

  • PRINCIPAL DISPLAY PANEL

    NDC 10135-0828-01
    Acetaminophen
    325 mg
    100 TABLETS

    828-01

  • INGREDIENTS AND APPEARANCE
    ACETAMINOPHEN 325MG 
    acetaminophen tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:10135-828
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ACETAMINOPHEN (UNII: 362O9ITL9D) (ACETAMINOPHEN - UNII:362O9ITL9D) ACETAMINOPHEN325 mg
    Inactive Ingredients
    Ingredient NameStrength
    POVIDONE K30 (UNII: U725QWY32X)  
    STARCH, CORN (UNII: O8232NY3SJ)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  
    Product Characteristics
    ColorwhiteScoreno score
    ShapeROUNDSize10mm
    FlavorImprint Code C;19
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:10135-828-01100 in 1 BOTTLE; Type 0: Not a Combination Product02/01/2026
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01302/01/2026
    Labeler - Marlex Pharmaceuticals Inc (782540215)